Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Shlien

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
NPJ Precision Oncology|May 5, 2026
An international framework for clinical translation of molecular classifiers in osteosarcomaAmanda E Marinoff, Michaela Nathrath, David S Shulman, et al.
NPJ Precision Oncology|September 17, 2022
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcomaDavid S Shulman, Sarah B Whittle, Didier Surdez, et al.
Cancer Discovery|February 10, 2021
Mutations in the RAS/MAPK Pathway Drive Replication Repair-Deficient Hypermutated Tumors and Confer Sensitivity to MEK InhibitionBrittany B Campbell, Melissa A Galati, Simone C Stone, et al.
Nature Communications|September 13, 2019
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomesJulian Musa, Florencia Cidre-Aranaz, Marie-Ming Aynaud, et al.
Nature Medicine|March 18, 2023
Diagnostic classification of childhood cancer using multiscale transcriptomicsFederico Comitani, Joshua O Nash, Sarah Cohen-Gogo, et al.
Nature Genetics|February 16, 2020
A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivoMasayuki Nakamori, Gagan B Panigrahi, Stella Lanni, et al.
Nature Communications|July 24, 2021
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survivalNathaniel D Anderson, Yael Babichev, Fabio Fuligni, et al.
Nature Communications|October 14, 2017
The driver landscape of sporadic chordomaPatrick S Tarpey, Sam Behjati, Matthew D Young, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade gliomaMatthew Mistry, Nataliya Zhukova, Daniele Merico, et al.
Nature Communications|September 13, 2016
Mutational signatures of ionizing radiation in second malignanciesSam Behjati, Gunes Gundem, David C Wedge, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
NPJ Precision Oncology|May 5, 2026
An international framework for clinical translation of molecular classifiers in osteosarcomaAmanda E Marinoff, Michaela Nathrath, David S Shulman, et al.
NPJ Precision Oncology|September 17, 2022
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcomaDavid S Shulman, Sarah B Whittle, Didier Surdez, et al.
Cancer Discovery|February 10, 2021
Mutations in the RAS/MAPK Pathway Drive Replication Repair-Deficient Hypermutated Tumors and Confer Sensitivity to MEK InhibitionBrittany B Campbell, Melissa A Galati, Simone C Stone, et al.
Nature Communications|September 13, 2019
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomesJulian Musa, Florencia Cidre-Aranaz, Marie-Ming Aynaud, et al.
Nature Medicine|March 18, 2023
Diagnostic classification of childhood cancer using multiscale transcriptomicsFederico Comitani, Joshua O Nash, Sarah Cohen-Gogo, et al.
Nature Genetics|February 16, 2020
A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivoMasayuki Nakamori, Gagan B Panigrahi, Stella Lanni, et al.
Nature Communications|July 24, 2021
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survivalNathaniel D Anderson, Yael Babichev, Fabio Fuligni, et al.
Nature Communications|October 14, 2017
The driver landscape of sporadic chordomaPatrick S Tarpey, Sam Behjati, Matthew D Young, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2015
BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade gliomaMatthew Mistry, Nataliya Zhukova, Daniele Merico, et al.
Nature Communications|September 13, 2016
Mutational signatures of ionizing radiation in second malignanciesSam Behjati, Gunes Gundem, David C Wedge, et al.
Pageof 11